0001437749-23-024472.txt : 20230822
0001437749-23-024472.hdr.sgml : 20230822
20230822194654
ACCESSION NUMBER: 0001437749-23-024472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230820
FILED AS OF DATE: 20230822
DATE AS OF CHANGE: 20230822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koconis John
CENTRAL INDEX KEY: 0001809589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37411
FILM NUMBER: 231194910
MAIL ADDRESS:
STREET 1: C/O TIMBER PHARMACEUTICALS, INC.
STREET 2: 900 E. HAMILTON AVENUE, SUITE 100
CITY: CAMPBELL
STATE: CA
ZIP: 95008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Timber Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001504167
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593843182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MOUNTAINVIEW ROAD, SUITE 100
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: (917) 697-3130
MAIL ADDRESS:
STREET 1: 3 MOUNTAINVIEW ROAD, SUITE 100
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharmX Corp
DATE OF NAME CHANGE: 20140304
FORMER COMPANY:
FORMER CONFORMED NAME: THOMPSON DESIGNS INC
DATE OF NAME CHANGE: 20101022
4
1
rdgdoc.xml
KOCONIS FORM 4
X0508
4
2023-08-20
0001504167
Timber Pharmaceuticals, Inc.
TMBR
0001809589
Koconis John
C/O TIMBER PHARMACEUTICALS, INC.
3 MOUNTAINVIEW RD, SUITE 100
WARREN
NJ
07059
1
CEO & Chairman
0
Common Stock, par value $0.001 per share
2023-08-20
4
A
0
70385
0
A
70785
D
On August 20, 2023, the Reporting Person was granted 70,385 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.001. 25% of the RSUs vest on August 20, 2024, and the remaining RSUs vest in 36 equal monthly installments beginning on September 20, 2024, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date; provided, however, that the RSUs will vest in full in the event that a "Change in Control" (as defined in the Issuer's 2020 Omnibus Incentive Plan) occurs while the Reporting Person remains in continuous service with the Issuer.
/s/ Joseph Lucchese, Power of Attorney
2023-08-22